Charles River Laboratories International (CRL) Gross Profit (2009 - 2025)

Charles River Laboratories International's Gross Profit history runs 17 years deep, the most recent figure standing at $744.9 million for Q4 2025.

• In Q4 2025, Gross Profit rose 305.17% year-over-year to $744.9 million; the TTM figure through Dec 2025 stood at $2.2 billion (up 41.55% YoY), while the FY2025 annual figure was $3.4 billion, up 46.17% from the prior year.
• Gross Profit was $744.9 million for Q4 2025 at Charles River Laboratories International, up from $596.7 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.9 billion in Q4 2021 to a low of -$363.1 million in Q4 2024.
• Historically, Gross Profit has averaged $589.4 million across 5 years, with a median of $473.6 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Gross Profit tumbled 152.25% in 2024, then jumped 305.17% in 2025.
• A 5-year view of Gross Profit shows it stood at $1.9 billion in 2021, then sank by 73.94% to $496.7 million in 2022, then jumped by 39.91% to $695.0 million in 2023, then slumped by 152.25% to -$363.1 million in 2024, then surged by 305.17% to $744.9 million in 2025.
• The last three Gross Profit figures came in at $744.9 million (Q4 2025), $596.7 million (Q3 2025), and $447.3 million (Q2 2025), per Business Quant data.